These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11557302)
1. Research with rats germane to medication for alcoholism: consequences of noncompliance. Reid ML; Hubbell CL; Douglass AV; Boedeker KL; Reid LD Alcohol; 2001 Jul; 24(3):169-77. PubMed ID: 11557302 [TBL] [Abstract][Full Text] [Related]
2. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Gardell LR; Reid LD; Boedeker KL; Liakos TM; Hubbell CL Alcohol Clin Exp Res; 1997 Dec; 21(9):1592-8. PubMed ID: 9438517 [TBL] [Abstract][Full Text] [Related]
3. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Reid LD; Pabello NG; Cramer CM; Hubbell CL Life Sci; 1997; 60(8):PL119-26. PubMed ID: 9042392 [TBL] [Abstract][Full Text] [Related]
4. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Cramer CM; Gardell LR; Boedeker KL; Harris JR; Hubbell CL; Reid LD Pharmacol Biochem Behav; 1998 Jun; 60(2):345-56. PubMed ID: 9632216 [TBL] [Abstract][Full Text] [Related]
7. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism. Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281 [TBL] [Abstract][Full Text] [Related]
8. Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone. Froehlich JC; Hausauer BJ; Rasmussen DD Alcohol Clin Exp Res; 2013 Oct; 37(10):1763-70. PubMed ID: 23875623 [TBL] [Abstract][Full Text] [Related]
10. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence. Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686 [TBL] [Abstract][Full Text] [Related]
13. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. Namkoong K; Farren CK; O'Connor PG; O'Malley SS J Clin Psychiatry; 1999 Jul; 60(7):449-53. PubMed ID: 10453799 [TBL] [Abstract][Full Text] [Related]
14. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals. Rasmussen DD; Kincaid CL; Froehlich JC Alcohol Clin Exp Res; 2015 Sep; 39(9):1832-41. PubMed ID: 26260061 [TBL] [Abstract][Full Text] [Related]